View in EDS HTML Full Text PDF Full Text

Rebiopsy Enhances Survival with Afatinib vs. Osimertinib in EGFR Exon 19 Deletion Non-Small Cell Lung Cancer: A Multicenter Study in Taiwan.

Saved in:
Bibliographic Details
Title: Rebiopsy Enhances Survival with Afatinib vs. Osimertinib in EGFR Exon 19 Deletion Non-Small Cell Lung Cancer: A Multicenter Study in Taiwan.
Authors: Kuo JS; Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin County, Douliu City 640, Taiwan., Chang CY; Division of Chest Medicine, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan.; Department of Nursing, Cardinal Tien Junior College of Healthcare and Management, New Taipei City 231, Taiwan., Chang SC; Division of Chest Medicine, Department of Internal Medicine, National Yang-Ming Chiao Tung University Hospital, Yilan County, Yilan City 260, Taiwan., Wei YF; Department of Internal Medicine, E-Da Cancer Hospital, I-Shou University, Kaohsiung City 824, Taiwan.; School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung City 824, Taiwan., Chen CY; Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin County, Douliu City 640, Taiwan.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei City 100, Taiwan.
Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2025 Jan 10; Vol. 32 (1). Date of Electronic Publication: 2025 Jan 10.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39851952
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Rebiopsy Enhances Survival with Afatinib vs. Osimertinib in EGFR Exon 19 Deletion Non-Small Cell Lung Cancer: A Multicenter Study in Taiwan.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kuo+JS%22">Kuo JS</searchLink>; Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin County, Douliu City 640, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chang+CY%22">Chang CY</searchLink>; Division of Chest Medicine, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan.; Department of Nursing, Cardinal Tien Junior College of Healthcare and Management, New Taipei City 231, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chang+SC%22">Chang SC</searchLink>; Division of Chest Medicine, Department of Internal Medicine, National Yang-Ming Chiao Tung University Hospital, Yilan County, Yilan City 260, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wei+YF%22">Wei YF</searchLink>; Department of Internal Medicine, E-Da Cancer Hospital, I-Shou University, Kaohsiung City 824, Taiwan.; School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung City 824, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+CY%22">Chen CY</searchLink>; Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin County, Douliu City 640, Taiwan.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei City 100, Taiwan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502503%22">Current oncology (Toronto, Ont.)</searchLink> [Curr Oncol] 2025 Jan 10; Vol. 32 (1). <i>Date of Electronic Publication: </i>2025 Jan 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9502503 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1718-7729 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211980052%22">11980052 </searchLink><i>NLM ISO Abbreviation: </i>Curr Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39851952
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/curroncol32010036
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Rebiopsy Enhances Survival with Afatinib vs. Osimertinib in EGFR Exon 19 Deletion Non-Small Cell Lung Cancer: A Multicenter Study in Taiwan.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kuo JS
      – PersonEntity:
          Name:
            NameFull: Chang CY
      – PersonEntity:
          Name:
            NameFull: Chang SC
      – PersonEntity:
          Name:
            NameFull: Wei YF
      – PersonEntity:
          Name:
            NameFull: Chen CY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 01
              Text: 2025 Jan 10
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1718-7729
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Current oncology (Toronto, Ont.)
              Type: main
ResultId 1